Catalysis Foundation for Health Taps BioFortis Labmatrix for Tuberculosis Biomarker Study

BioFortis said the foundation will use the platform to collect and manage patient specimen data and clinical information, track shipment status, analyze data from thousands of patient biospecimens, and view real-time study results from pre-built or ad hoc data queries.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.